Modeling doxorubicin transport to improve intratumoral drug delivery to RF ablated tumors
- 4 December 2007
- journal article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 124 (1-2), 11-19
- https://doi.org/10.1016/j.jconrel.2007.08.023
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Recurrence after liver resection for hepatocellular carcinoma: Risk factors, treatment, and outcomesSurgery, 2007
- Antitumor efficacy and local distribution of doxorubicin via intratumoral delivery from polymer millirodsJournal of Biomedical Materials Research Part A, 2006
- Combined radiofrequency ablation and doxorubicin‐eluting polymer implants for liver cancer treatmentJournal of Biomedical Materials Research Part A, 2006
- Nonlinear Dependence of Hydraulic Conductivity on Tissue Deformation During Intratumoral InfusionAnnals of Biomedical Engineering, 2006
- Percutaneous laser ablation in patients with isolated unresectable liver metastases from colorectal cancer: Results of a phase II studyActa Oncologica, 2006
- Local release of dexamethasone from polymer millirods effectively prevents fibrosis after radiofrequency ablationJournal of Biomedical Materials Research Part A, 2005
- Cell cavities increase tortuosity in brain extracellular spaceJournal of Theoretical Biology, 2005
- Local carboplatin delivery and tissue distribution in livers after radiofrequency ablationJournal of Biomedical Materials Research, 2003
- Quantification of in vivo doxorubicin transport from PLGA millirods in thermoablated rat liversJournal of Controlled Release, 2003
- Membrane‐encased polymer millirods for sustained release of 5‐fluorouracilJournal of Biomedical Materials Research, 2002